The News Forum - Energy Creates Launches Nation-Wide Scholarship Contest Offering $500,000 in Prizes to Youth 15 – 25
May 06, 2024 05:00 ET
|
The News Forum Inc.
$100,000 scholarship for students 15-25. Watch the documentary and enter the contest - easy. www.energycreates.com
Bow Valley College endorses Colleges and Institutes Canada Indigenous Education Protocol
April 29, 2024 19:13 ET
|
Bow Valley College
Calgary, April 29, 2024 (GLOBE NEWSWIRE) -- Today, Bow Valley College reaffirmed its commitment to reconciliation and Indigenous learners by signing the Indigenous Education Protocol. Developed...
Boys & Girls Clubs of Delaware, Navient to host May 4 college planning conference
April 25, 2024 14:06 ET
|
Navient Corporation
DOVER, Del., April 25, 2024 (GLOBE NEWSWIRE) -- Boys & Girls Clubs of Delaware, a seasoned leader in youth development, and Navient (Nasdaq: NAVI), a leader in technology-enabled education...
Dr. Dushyant Singh Joins AGA in Tulsa
April 19, 2024 08:40 ET
|
GI Alliance
Tulsa, OK, April 19, 2024 (GLOBE NEWSWIRE) -- With more than a decade of experience, Adult Gastroenterology Associates is excited to announce the addition of Dr. Dushyant Singh, a physician...
Veterans, Supporters to Move American Flag 1,600 Miles From Philadelphia through Chicago
April 11, 2024 09:00 ET
|
Team Red, White & Blue
1,600-mile relay to travel from PA to IL to support veterans' health and wellness.
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software
March 22, 2024 08:00 ET
|
Retrieve Medical, Inc.
RETRIEVE MEDICAL HOLDINGS, INC. (RMHI) ANNOUNCES STUDY UPDATE RESULTS UTILIZING RETRIEVE DxTM SOFTWARE
US FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) – the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives
March 20, 2024 02:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult...
US FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) – the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives
March 20, 2024 02:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult...
BLUE FOUNDATION ANNOUNCES $18,500 IN 2024 SCHOLARSHIPS
March 12, 2024 10:00 ET
|
Blue Federal Credit Union
Cheyenne, Wyoming, March 12, 2024 (GLOBE NEWSWIRE) -- Blue Federal Credit Union and Blue Foundation are proud to once again, offer a total of $18,500 in higher education scholarships to members of...
Universal Tennis Foundation Names 2024 Hurd Award Champions
March 11, 2024 12:30 ET
|
Universal Tennis
Palo Alto, CA, March 11, 2024 (GLOBE NEWSWIRE) -- On Sunday, Ethan Quinn and Fiona Crawley were named Champions of the 2024 Universal Tennis Foundation Hurd Awards. The award winners were announced...